These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
480 related articles for article (PubMed ID: 26247726)
1. NSC-87877 inhibits DUSP26 function in neuroblastoma resulting in p53-mediated apoptosis. Shi Y; Ma IT; Patel RH; Shang X; Chen Z; Zhao Y; Cheng J; Fan Y; Rojas Y; Barbieri E; Chen Z; Yu Y; Jin J; Kim ES; Shohet JM; Vasudevan SA; Yang J Cell Death Dis; 2015 Aug; 6(8):e1841. PubMed ID: 26247726 [TBL] [Abstract][Full Text] [Related]
2. Dual-specificity phosphatase 26 is a novel p53 phosphatase and inhibits p53 tumor suppressor functions in human neuroblastoma. Shang X; Vasudevan SA; Yu Y; Ge N; Ludwig AD; Wesson CL; Wang K; Burlingame SM; Zhao YJ; Rao PH; Lu X; Russell HV; Okcu MF; Hicks MJ; Shohet JM; Donehower LA; Nuchtern JG; Yang J Oncogene; 2010 Sep; 29(35):4938-46. PubMed ID: 20562916 [TBL] [Abstract][Full Text] [Related]
3. NSC-87877, inhibitor of SHP-1/2 PTPs, inhibits dual-specificity phosphatase 26 (DUSP26). Song M; Park JE; Park SG; Lee DH; Choi HK; Park BC; Ryu SE; Kim JH; Cho S Biochem Biophys Res Commun; 2009 Apr; 381(4):491-5. PubMed ID: 19233143 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of dual-specificity phosphatase 26 by ethyl-3,4-dephostatin: Ethyl-3,4-dephostatin as a multiphosphatase inhibitor. Seo H; Cho S Pharmazie; 2016 Apr; 71(4):196-200. PubMed ID: 27209699 [TBL] [Abstract][Full Text] [Related]
5. MT-4 suppresses resistant ovarian cancer growth through targeting tubulin and HSP27. Pai HC; Kumar S; Shen CC; Liou JP; Pan SL; Teng CM PLoS One; 2015; 10(4):e0123819. PubMed ID: 25874627 [TBL] [Abstract][Full Text] [Related]
6. DUSP26 negatively affects the proliferation of epithelial cells, an effect not mediated by dephosphorylation of MAPKs. Patterson KI; Brummer T; Daly RJ; O'Brien PM Biochim Biophys Acta; 2010 Sep; 1803(9):1003-12. PubMed ID: 20347885 [TBL] [Abstract][Full Text] [Related]
7. A novel amplification target, DUSP26, promotes anaplastic thyroid cancer cell growth by inhibiting p38 MAPK activity. Yu W; Imoto I; Inoue J; Onda M; Emi M; Inazawa J Oncogene; 2007 Feb; 26(8):1178-87. PubMed ID: 16924234 [TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53. Van Maerken T; Ferdinande L; Taildeman J; Lambertz I; Yigit N; Vercruysse L; Rihani A; Michaelis M; Cinatl J; Cuvelier CA; Marine JC; De Paepe A; Bracke M; Speleman F; Vandesompele J J Natl Cancer Inst; 2009 Nov; 101(22):1562-74. PubMed ID: 19903807 [TBL] [Abstract][Full Text] [Related]
9. MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer. Xu L; Chen S; Bergan RC Oncogene; 2006 May; 25(21):2987-98. PubMed ID: 16407830 [TBL] [Abstract][Full Text] [Related]
10. A small-molecule inhibitor of UBE2N induces neuroblastoma cell death via activation of p53 and JNK pathways. Cheng J; Fan YH; Xu X; Zhang H; Dou J; Tang Y; Zhong X; Rojas Y; Yu Y; Zhao Y; Vasudevan SA; Zhang H; Nuchtern JG; Kim ES; Chen X; Lu F; Yang J Cell Death Dis; 2014 Feb; 5(2):e1079. PubMed ID: 24556694 [TBL] [Abstract][Full Text] [Related]
11. A monomer purified from Paris polyphylla (PP-22) triggers S and G2/M phase arrest and apoptosis in human tongue squamous cell carcinoma SCC-15 by activating the p38/cdc25/cdc2 and caspase 8/caspase 3 pathways. Ke JY; Zhang W; Gong RS; Cen WJ; Huang HQ; Li YR; Kong WD; Jiang JW Tumour Biol; 2016 Nov; 37(11):14863-14872. PubMed ID: 27644244 [TBL] [Abstract][Full Text] [Related]
12. Atomic structure of dual-specificity phosphatase 26, a novel p53 phosphatase. Lokareddy RK; Bhardwaj A; Cingolani G Biochemistry; 2013 Feb; 52(5):938-48. PubMed ID: 23298255 [TBL] [Abstract][Full Text] [Related]
13. Dual-specificity phosphatase 26 protects against kidney injury caused by ischaemia-reperfusion through restraint of TAK1-JNK/p38-mediated apoptosis and inflammation of renal tubular epithelial cells. Xiang H; Li Z; Li Y; Zheng J; Dou M; Xue W; Wu X Toxicol Appl Pharmacol; 2024 Jun; 487():116954. PubMed ID: 38705402 [TBL] [Abstract][Full Text] [Related]
14. HGFK1 inhibits bone metastasis in breast cancer through the TAK1/p38 MAPK signaling pathway. Yao Y; Fang ZP; Chen H; Yue L; Min DL; Tang LN; Yu WX; Kung HF; Lin MC; Shen Z Cancer Gene Ther; 2012 Sep; 19(9):601-8. PubMed ID: 22767217 [TBL] [Abstract][Full Text] [Related]
15. Oridonin induces apoptosis in SW1990 pancreatic cancer cells via p53- and caspase-dependent induction of p38 MAPK. Bu HQ; Liu DL; Wei WT; Chen L; Huang H; Li Y; Cui JH Oncol Rep; 2014 Feb; 31(2):975-82. PubMed ID: 24297112 [TBL] [Abstract][Full Text] [Related]
16. Protein phosphatase Dusp26 associates with KIF3 motor and promotes N-cadherin-mediated cell-cell adhesion. Tanuma N; Nomura M; Ikeda M; Kasugai I; Tsubaki Y; Takagaki K; Kawamura T; Yamashita Y; Sato I; Sato M; Katakura R; Kikuchi K; Shima H Oncogene; 2009 Feb; 28(5):752-61. PubMed ID: 19043453 [TBL] [Abstract][Full Text] [Related]
17. The p53 pathway is synergized by p38 MAPK signaling to mediate 11,11'-dideoxyverticillin-induced G2/M arrest. Chen Y; Miao ZH; Zhao WM; Ding J FEBS Lett; 2005 Jul; 579(17):3683-90. PubMed ID: 15963507 [TBL] [Abstract][Full Text] [Related]
18. Identification of novel dual-specificity phosphatase 26 inhibitors by a hybrid virtual screening approach based on pharmacophore and molecular docking. Ren JX; Cheng Z; Huang YX; Zhao JF; Guo P; Zou ZM; Xie Y Biomed Pharmacother; 2017 May; 89():376-385. PubMed ID: 28249240 [TBL] [Abstract][Full Text] [Related]
19. Clostridium difficile toxin A-induced colonocyte apoptosis involves p53-dependent p21(WAF1/CIP1) induction via p38 mitogen-activated protein kinase. Kim H; Kokkotou E; Na X; Rhee SH; Moyer MP; Pothoulakis C; Lamont JT Gastroenterology; 2005 Dec; 129(6):1875-88. PubMed ID: 16344056 [TBL] [Abstract][Full Text] [Related]
20. Cytokine regulation by MAPK activated kinase 2 in keratinocytes exposed to sulfur mustard. Yego EC; Dillman JF Toxicol In Vitro; 2013 Oct; 27(7):2067-75. PubMed ID: 23851002 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]